Ishita Drugs and Industries Limited (BOM:524400)
India · Delayed Price · Currency is INR 76.54
+0.54 (0.71%)
At close: Aug 21, 2026
BOM:524400 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 1.46 | 5.68 | 18.25 | 6.06 | 19.87 |
Short-Term Investments | - | 66.54 | 77.8 | 60.5 | 59.45 | 36.69 |
Cash & Short-Term Investments | 67.99 | 67.99 | 83.49 | 78.75 | 65.51 | 56.56 |
Cash Growth | -18.56% | -18.56% | 6.02% | 20.21% | 15.83% | 4.28% |
Accounts Receivable | - | 10.08 | 18.98 | 6.99 | 18 | 5.42 |
Receivables | - | 17.89 | 21.37 | 7 | 20.03 | 5.75 |
Inventory | - | 9.23 | 44.65 | 10.64 | 15.98 | 37.93 |
Prepaid Expenses | - | 0.31 | 0.32 | 0.18 | 0.26 | 0.23 |
Other Current Assets | - | - | 0 | - | - | - |
Total Current Assets | - | 95.42 | 149.83 | 96.57 | 101.78 | 100.47 |
Property, Plant & Equipment | - | 26.3 | 8.79 | 8.05 | 8.89 | 8.85 |
Long-Term Investments | - | 3.55 | 3.55 | 2.71 | 2.71 | 2.71 |
Total Assets | - | 126.04 | 162.96 | 108.09 | 114.07 | 112.54 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 5.6 | 9.49 | 4.58 | 8.55 | 20.39 |
Accrued Expenses | - | 1.57 | 0.96 | 1.23 | 0.99 | 0.89 |
Short-Term Debt | - | 0.47 | 38.14 | - | 9.6 | - |
Current Income Taxes Payable | - | 1.9 | 2.52 | 1.36 | 0.7 | 3.16 |
Other Current Liabilities | - | 0.35 | 2.94 | 1.49 | 2.28 | 1.85 |
Total Current Liabilities | - | 9.89 | 54.05 | 8.67 | 22.13 | 26.29 |
Long-Term Debt | - | 0.35 | 0.89 | - | - | - |
Long-Term Deferred Tax Liabilities | - | 0.13 | 0.12 | 0.2 | 0.21 | 0.29 |
Other Long-Term Liabilities | - | - | 0 | - | 0 | 0 |
Total Liabilities | - | 10.36 | 55.06 | 8.87 | 22.34 | 26.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 29.9 | 29.9 | 29.9 | 29.9 | 29.9 |
Retained Earnings | - | - | 76.33 | 67.65 | 60.16 | 54.39 |
Comprehensive Income & Other | - | 85.78 | 1.66 | 1.66 | 1.66 | 1.66 |
Shareholders' Equity | 115.68 | 115.68 | 107.9 | 99.22 | 91.73 | 85.96 |
Total Liabilities & Equity | - | 126.04 | 162.96 | 108.09 | 114.07 | 112.54 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 0.82 | 0.82 | 39.03 | - | 9.6 | - |
Net Cash (Debt) | 67.17 | 67.17 | 44.46 | 78.75 | 55.9 | 56.56 |
Net Cash Growth | 51.09% | 51.09% | -43.54% | 40.86% | -1.15% | 5.10% |
Net Cash Per Share | 22.44 | 22.43 | 14.87 | 26.33 | 18.70 | 18.91 |
Filing Date Shares Outstanding | 2.99 | 3.01 | 2.99 | 2.99 | 2.99 | 2.99 |
Total Common Shares Outstanding | 2.99 | 3.01 | 2.99 | 2.99 | 2.99 | 2.99 |
Working Capital | - | 85.54 | 95.79 | 87.9 | 79.65 | 74.18 |
Book Value Per Share | 38.47 | 38.47 | 36.08 | 33.18 | 30.68 | 28.75 |
Tangible Book Value | 115.68 | 115.68 | 107.9 | 99.22 | 91.73 | 85.96 |
Tangible Book Value Per Share | 38.47 | 38.47 | 36.08 | 33.18 | 30.68 | 28.75 |
Land | - | - | 0.9 | 0.9 | 0.9 | 0.9 |
Buildings | - | - | 7.17 | 7.17 | 7.17 | 7.17 |
Machinery | - | - | 40.3 | 39.49 | 39.22 | 37.88 |